Clinical Trial Update: A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015 and Co-administration of BR1015-1 and BR1015-2 Under Fasting Conditions [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the pharmacokinetics and safety of BR1015 alone and in combination with BR1015-1 and BR1015-2 under fasting conditions has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• BR1015
• BR1015-1
• BR1015-2

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: Essential Hypertension | Phase 1 | Status: COMPLETED